Form 4: Hims & Hers Health Director David B. Wells Reports Stock Transactions
SEC Form 4 Filing
Director David B. Wells reports the vesting and conversion of Restricted Stock Units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.
Summary
- On June 6, 2024, David B. Wells, a director of Hims & Hers Health, Inc., reported transactions involving the company's stock.
- Wells acquired 19,707 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Wells directly owns 175,946 shares of Class A Common Stock.
- The RSUs vested on June 6, 2024, which was the date of the company's 2024 annual stockholders meeting.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports stock transactions by a company director.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the actions of company leadership.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the standard vesting of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: RSUs vested and converted to Class A Common Stock; date of the company's 2024 annual stockholders meeting. |
| 06/10/2024 | Date of report filing. |
| 06/15/2024 | Alternative vesting date for RSUs, if earlier than the annual meeting date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.